Atlantic City, NJ - Opening statements began today at a trial involving claims, that the widely prescribed acne medication Accutane caused inflammatory bowel disease, known as IBD, in a female plaintiff which led to the removal of her colon.
Retrial of Accutane Lawsuit Begins After $10.5 Million Verdict Reversed
Posted by David Siegel on Jan 30, 2014 4:00:39 PM
Topics: Kendall v. Roche, accutane, Pharmaceutical
The $10.5M Accutane verdict in Kendall v. Roche has been reversed, and remanded for retrial, for reasons similar to last year's reversal of McCarrell v. Roche.
Topics: Toxic Torts, Kendall v. Roche, Products Liability, accutane, Pharmaceutical